Chen Bihua
CIK 1599214
Transactions on file
27
Open-market buys
2
Win rate (buys)
50%
2 scored
Avg % since filing (buys)
-20.4%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Buy | 312,500 | $5.00M | +34.4% | open → | |
| 2026-08-10 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | C | 1,701,541 | $0.00 | — | open → | |
| 2026-08-10 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | C | 1,599,993 | $0.00 | — | open → | |
| 2026-07-06 | 2026-07-01 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Other | 130,865 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Other | 1,704,862 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Other | 2,692,459 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Other | 4,528,186 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-14 | AARD Aardvark Therapeutics, Inc. | Other | C | 800,189 | — | — | open → |
| 2025-02-19 | 2025-02-14 | AARD Aardvark Therapeutics, Inc. | Other | Buy | 187,500 | $3.00M | -75.3% | open → |
| 2025-05-14 | 2025-05-12 | OKUR OnKure Therapeutics, Inc. | 10% | Sale | 24,300 | $48.4K | +29.6% | open → |
| 2025-05-19 | 2025-05-15 | OKUR OnKure Therapeutics, Inc. | Other | Sale | 1,813,439 | $3.35M | +39.5% | open → |
| 2026-04-30 | 2026-04-28 | DRUG BRIGHT MINDS BIOSCIENCES INC. | Sale | 109,331 | $9.79M | — | open → | |
| 2025-12-15 | 2025-12-11 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 30,029 | $344.0K | -61.5% | open → | |
| 2025-12-08 | 2025-12-04 | EYPT EyePoint, Inc. | Sale | 60,000 | $942.2K | -74.4% | open → | |
| 2025-10-01 | 2025-09-30 | MLTX MoonLake Immunotherapeutics | Sale | 5,827 | $40.6K | +124.4% | open → | |
| 2025-10-01 | 2025-09-29 | MLTX MoonLake Immunotherapeutics | Sale | 2,800,000 | $18.51M | +136.3% | open → | |
| 2025-10-01 | 2025-09-29 | MLTX MoonLake Immunotherapeutics | Sale | 3,390,943 | $25.70M | +106.1% | open → | |
| 2025-10-01 | 2025-09-29 | MLTX MoonLake Immunotherapeutics | Sale | 232,460 | $1.95M | +86.0% | open → | |
| 2025-10-01 | 2025-09-29 | MLTX MoonLake Immunotherapeutics | Sale | 70,748 | $663.6K | +66.5% | open → | |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 639,110 | $6.85M | -75.2% | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 5,598,425 | $60.02M | -75.2% | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 1,905,046 | — | — | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 1,762,760 | — | — | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 284,571 | — | — | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Grant | 760,496 | $8.15M | -75.2% | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Exer. | 4,172,126 | — | — | open → |
| 2025-08-13 | 2025-08-11 | BBOT BridgeBio Oncology Therapeutics, Inc. | Director10% | Disp. | 152,940 | $0.00 | — | open → |
